Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)
US12415803B2 · kind B2 · utility
0Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2019 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Sep 12, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fused imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.